NCT00297128 Preoperative Chemoradiation With Capecitabine and Cetuximab Status COMPLETED Phase PHASE2
NCT00292955 Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma Status UNKNOWN Phase PHASE2
NCT00291707 Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00290615 Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00288054 S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT00276744 Individualized Drug Treatment for Treating Patients With Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00275041 Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00265941 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00265850 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00265811 Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery Status COMPLETED Phase PHASE3
NCT00254137 Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE2
NCT00252564 Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00251498 Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00251485 A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00251381 Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. Status UNKNOWN Phase PHASE2
NCT00240682 Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR Status COMPLETED Phase PHASE2
NCT00232505 Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00226941 A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00226239 Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer Status COMPLETED Phase PHASE2